Skip to main content

Table 3 Serum Galectin-3 concentrations in pg/mL for the respective groups at baseline and follow-up examination

From: Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease

Groups

Baseline (n; median [IQR])

Follow-up (n; median [IQR])

P-value

Control

21; 6380.5 [4462.49–7656.29]

18; 5152.05 [4681.11–6713.43]

NS

Stage B1

39; 5140.91 [4094.13–7047.52]

32; 5851.08 [4033.94–7557.08]

NS

Stage B2

9; 4791.34 [4334.51–4969.2]

12; 5352.87 [4261.51–8612.47]

NS

Stage C

14; 6556.58 [4713.07–8767.38]

7; 5056.82 [4256.65–7119.38]

NS

  1. IQR Interquartile range, NS Non-significant. The p-value denotes the probability of the change in Galectin-3 concentrations from baseline to follow-up examination for each group. Data are presented as median (interquartile range)